INS and choreatic disease: The lack of significant difference in treatment intervals both between the insulin-control-only group and the additional anti-chorea medication group as well as between the complete response and poor response groups suggested that the timing of treatment intervention may not be a critical contributor to patient outcomes which appeared to depend more on the severity of the underlying condition.